The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

28 Jun 2017 12:10

RNS Number : 4313J
Aberdeen Latin American Inc Fd Ltd
28 June 2017
 

Aberdeen Asset Management PLC announces the unaudited net asset values (NAVs) of the following investment companies as at close of business on 27 June 2017. Unless otherwise disclosed, the NAVs have been calculated in accordance with the recommendations of the Association of Investment Companies. In particular: (1) financial assets have been valued on a fair value basis using bid prices, or, if more appropriate, a last trade basis; (2) debt is valued at par and, where applicable, debt is also separately valued at market value (3) diluted NAVs are disclosed where applicable (for this purpose, treasury shares are excluded for the purposes of calculation); and (4) provisions for performance fees are included where applicable.

 

Aberdeen Latin American Income Fund Limited Undiluted
Excluding Income
81.42p
Ordinary
Aberdeen Latin American Income Fund Limited Undiluted
Including Income
83.75p
Ordinary
 
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVOKFDQKBKDKAB
Date   Source Headline
7th Jun 20221:23 pmRNSNet Asset Value(s)
6th Jun 20224:54 pmRNSGearing disclosure
6th Jun 20224:06 pmRNSQuarterly disclosure
6th Jun 20222:44 pmRNSNet Asset Value(s)
31st May 202212:43 pmRNSNet Asset Value(s)
30th May 20223:51 pmRNSGearing disclosure
30th May 202212:37 pmRNSNet Asset Value(s)
27th May 20221:13 pmRNSNet Asset Value(s)
26th May 202212:56 pmRNSNet Asset Value(s)
25th May 20221:23 pmRNSNet Asset Value(s)
24th May 202212:25 pmRNSNet Asset Value(s)
23rd May 20224:14 pmRNSGearing disclosure
23rd May 20221:07 pmRNSNet Asset Value(s)
20th May 202212:44 pmRNSNet Asset Value(s)
19th May 202212:27 pmRNSNet Asset Value(s)
18th May 20224:55 pmRNSPortfolio disclosure
18th May 202212:47 pmRNSNet Asset Value(s)
17th May 20221:02 pmRNSNet Asset Value(s)
16th May 20225:00 pmRNSDoc re. Half Yearly Report
16th May 20224:08 pmRNSGearing disclosure
16th May 20221:08 pmRNSNet Asset Value(s)
13th May 20221:00 pmRNSNet Asset Value(s)
12th May 202212:32 pmRNSNet Asset Value(s)
11th May 202212:42 pmRNSNet Asset Value(s)
10th May 20221:04 pmRNSNet Asset Value(s)
9th May 20222:08 pmRNSGearing disclosure
9th May 20221:20 pmRNSNet Asset Value(s)
6th May 20225:17 pmRNSMonth End Net Asset Value(s)
6th May 202212:08 pmRNSNet Asset Value(s)
5th May 202212:30 pmRNSNet Asset Value(s)
4th May 202212:46 pmRNSNet Asset Value(s)
4th May 20227:00 amRNSHalf-year Report
3rd May 20225:50 pmRNSGearing Disclosures
29th Apr 202211:37 amRNSNet Asset Value(s)
28th Apr 202212:13 pmRNSNet Asset Value(s)
27th Apr 202212:52 pmRNSNet Asset Value(s)
26th Apr 20222:14 pmRNSSecond Interim Dividend
26th Apr 202212:37 pmRNSNet Asset Value(s)
25th Apr 20222:51 pmRNSGearing Disclosure
25th Apr 20221:05 pmRNSNet Asset Value(s)
22nd Apr 20221:21 pmRNSNet Asset Value(s)
21st Apr 202212:38 pmRNSNet Asset Value(s)
20th Apr 202212:28 pmRNSNet Asset Value(s)
19th Apr 20226:00 pmRNSGearing Disclosure
19th Apr 20221:07 pmRNSNet Asset Value(s)
19th Apr 202210:19 amRNSPortfolio Disclosures
14th Apr 202212:39 pmRNSNet Asset Value(s)
13th Apr 202212:05 pmRNSNet Asset Value(s)
12th Apr 202212:26 pmRNSNet Asset Value(s)
11th Apr 20222:13 pmRNSGearing disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.